Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.
Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1–20.
Kubo N, Kochi S, Ariyama I, et al. Pseudomembranous colitis after Helicobacter pylori eradication therapy. Kansenshogaku Zasshi. 2006;80:51–5 (in Japanese).
Nakashima Y. A case of pseudomembranous colitis after eradication therapy for Helicobacter pylori. Jpn J Prim Care. 2004;27:203–4.
Hudson N, Brydon WB, Eastwood MA, et al. Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen. Aliment Pharmacol Ther. 1995;9:47–50.
Aoki T, Kataoka M, Sou Y, et al. A case of pseudomembranous colitis concomitant with toxic megacolon and paralytic ileus. Nihon Shokakibyo Gakkai Zasshi. 2012;109:1386–93 (in Japanese).
Sogaard KK, Ejlertsen T, Schonheyder HC. Clostridium difficile 027-associated pseudomembranous colitis after short-term treatment with cefuroxime and cephalexin in an elderly orthopedic patient: a case report. BMC Res Notes. 2012;5:609.
Villanueva-Saenz E, Herrera JT, Martinez-Hernandez Magro P. Toxic megacolon secondary to pseudomembranous colitis. Rev Gastroenterol Mex. 2001;66:141–5.
Vanpoucke H, De Baere T, Claeys G, et al. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens. Clin Microbiol Infect. 2001;7:55–64.
Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003. CMAJ. 2004;171:466–72.
McFarland LV, Mulligan ME, Kwork RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204–10.
Thibaut A, Miller MA, Gaese C, et al. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol. 1991;12:345–8.
Bliss DZ, Johnson S, Savik K, et al. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129:1012–9.
Kwok CS, Arthur AK, Anibueze CI, et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107:1011–9.
Cohen SH, Gerding DN, Johnson S, et al. Clinical practice for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.
Malfertheiner P, Megraud F, O’Morain CA, European Helicobacter Study Group, et al. Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report. Gut. 2012;61:646–64.